戻る Agenda
Session 10: From Clinical Trial Material to Commercial Product
Session Chair(s)
Albert S. Yehaskel, MBA
President and CEO
Refuah Global Pharmaceutical Development, Inc., United States
- Begin with the End in Mind
- What is a Target Product Profile
- Design Your Ideal Label
- TOC for a Target Product Profile (TPP)
- Changes to CTMs
- References